Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,036,839
+$76,431 QoQ
Shares Held
8,020
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#2,335
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $10,204,212 across 14 Drug Manufacturers - General names. JNJ ranks #2 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,220 | $3,326,680 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
8,020 | $2,036,839 | |
| 3 | AMGN |
Amgen Inc
|
3,675 | $1,330,791 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
8,055 | $1,017,668 | |
| 5 | LLY |
ELI LILLY & Co
|
641 | $768,834 | |
| 6 | NVO |
Novo Nordisk A S
|
11,256 | $539,612 | |
| 7 | PFE |
Pfizer Inc
|
18,621 | $448,393 | |
| 8 | NVS |
Novartis AG
|
1,774 | $278,021 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,036,839 | 8,020 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,960,408 | 8,020 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,673,811 | 8,088 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,503,385 | 8,108 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,201,378 | 7,865 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,324,232 | 7,985 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $1,172,289 | 8,106 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,264,230 | 7,801 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,140,048 | 7,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,233,882 | 7,800 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,427,431 | 9,107 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,413,742 | 9,077 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $1,559,032 | 9,419 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $1,459,325 | 9,415 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $1,662,629 | 9,412 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $1,537,054 | 9,409 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $1,456,469 | 8,205 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $1,453,640 | 8,202 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $1,403,116 | 8,202 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $1,324,623 | 8,202 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $1,351,032 | 8,201 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $8,231 | 1,352,783 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $1,317,585 | 8,372 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $1,227,664 | 8,246 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $1,182,838 | 8,411 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $1,102,934 | 8,411 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||